Quantbot Technologies LP Arcturus Therapeutics Holdings Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$23.94 - $32.36 $76,608 - $103,552	-3,200 Reduced 43.84%	4,100 $117,000
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $73,658 - $119,945	5,004 Added 217.94%	7,300 $174,000
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $32,465 - $52,945	2,296 New	2,296 $38,000
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $15,876 - $35,613	-900 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$34.2 - $47.56 $17,100 - $23,780	500 Added 125.0%	900 $33,000
Q3 2021 Nov 09, 2021	BUY	$27.88 - $58.25 $11,152 - $23,300	400 New	400 $19,000
Q2 2021 Aug 12, 2021	SELL	$25.79 - $42.11 $33,165 - $54,153	-1,286 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$38.75 - $86.92 $49,832 - $111,779	1,286 New	1,286 $53,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.